These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2493405

  • 1. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model.
    Doody KJ, Dunn RC, Buttram VC.
    Fertil Steril; 1989 Mar; 51(3):509-12. PubMed ID: 2493405
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effect of intraperitoneally administered calcium channel blockade and recombinant tissue plasminogen activator to prevent adhesion formation in an animal model.
    Dunn RC, Steinleitner AJ, Lambert H.
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1327-30. PubMed ID: 1903594
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue-type plasminogen activator and adhesion prevention.
    Dunn RC.
    Prog Clin Biol Res; 1993 May; 381():213-20. PubMed ID: 8316565
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro.
    Qin F, Ma Y, Li X, Wang X, Wei Y, Hou C, Lin S, Hou L, Wang C.
    Int J Nanomedicine; 2015 May; 10():3699-716. PubMed ID: 26056449
    [Abstract] [Full Text] [Related]

  • 15. Experimental adhesion prophylaxis with recombinant tissue plasminogen activator.
    Vipond MN, Whawell SA, Scott-Coombes DM, Thompson JN, Dudley HA.
    Ann R Coll Surg Engl; 1994 Nov; 76(6):412-5. PubMed ID: 7702327
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery.
    Practice Committee of the American Society for Reproductive Medicine, Society of Reproductive Surgeons.
    Fertil Steril; 2007 Jul; 88(1):21-6. PubMed ID: 17613300
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of peritoneal adhesions: a promising role for gene therapy.
    Atta HM.
    World J Gastroenterol; 2011 Dec 14; 17(46):5049-58. PubMed ID: 22171139
    [Abstract] [Full Text] [Related]

  • 20. The prevention effects of cryptotanshinone nanoemulsion on postoperative peritoneal adhesions.
    Chengxi W, Rishuo G, QuLiang G, Laiyou W, Lianbing H, Linghao Q.
    Drug Dev Ind Pharm; 2019 May 14; 45(5):695-702. PubMed ID: 30560692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.